These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 82710)

  • 1. Acetylator status and response to phenelzine.
    Tilstone WJ; Johnstone EC
    Lancet; 1978 Nov; 2(8100):1151-2. PubMed ID: 82710
    [No Abstract]   [Full Text] [Related]  

  • 2. Acetylator status and response to phenelzine in depressed patients.
    Johnstone EC; Marsh W
    Lancet; 1973 Mar; 1(7803):567-70. PubMed ID: 4120641
    [No Abstract]   [Full Text] [Related]  

  • 3. The relationship between acetylator status and inhibition of monoamine oxidase, excretion of free drug and antidepressant response in depressed patients on phenelzine.
    Johnstone EC
    Psychopharmacologia; 1976 Apr; 46(3):289-94. PubMed ID: 951464
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The relationship between response to phenelzine and acetylator status in depressed patients.
    Johnstone EC; Marsh W
    Proc R Soc Med; 1973 Sep; 66(9):947-9. PubMed ID: 4616245
    [No Abstract]   [Full Text] [Related]  

  • 5. Acetylation phenotype, platelet monoamine oxidase inhibition, and the effectiveness of phenelzine in depression.
    Davidson J; McLeod MN; Blum MR
    Am J Psychiatry; 1978 Apr; 135(4):467-9. PubMed ID: 345825
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship between acetylator status and response to phenelzine.
    Johnstone EC
    Mod Probl Pharmacopsychiatry; 1975; 10():30-7. PubMed ID: 1101047
    [No Abstract]   [Full Text] [Related]  

  • 7. Phenelzine: acetylator status and clinical response.
    Sanders GL; Rawlins MD
    Br J Clin Pharmacol; 1979 May; 7(5):451-2. PubMed ID: 475942
    [No Abstract]   [Full Text] [Related]  

  • 8. Acetylator status and response to phenelzine.
    Tyrer P; Gardner M
    Lancet; 1978 Nov; 2(8097):994-5. PubMed ID: 82019
    [No Abstract]   [Full Text] [Related]  

  • 9. Acetylator phenotype in relation to monoamine oxidase inhibitor antidepressant drug therapy.
    Whitford GM
    Int Pharmacopsychiatry; 1978; 13(2):126-32. PubMed ID: 352977
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The influence of acetylator phenotype on the outcome of treatment with phenelzine, in a clinical trial.
    Marshall EF; Mountjoy CQ; Campbell IC; Garside RF; Leitch IM; Roth M
    Br J Clin Pharmacol; 1978 Sep; 6(3):247-54. PubMed ID: 356868
    [No Abstract]   [Full Text] [Related]  

  • 11. Interaction of phenelzine and nitrazepam in a slow acetylator.
    Harris AL; McIntyre N
    Br J Clin Pharmacol; 1981 Aug; 12(2):254-5. PubMed ID: 7306441
    [No Abstract]   [Full Text] [Related]  

  • 12. Metabolic acetylation of phenelzine in rats.
    Mozayani A; Coutts RT; Danielson TJ; Baker GB
    Res Commun Chem Pathol Pharmacol; 1988 Dec; 62(3):397-406. PubMed ID: 3222522
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetically determined variability in acetylation and oxidation. Therapeutic implications.
    Clark DW
    Drugs; 1985 Apr; 29(4):342-75. PubMed ID: 2859977
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Letter: Phenelzine and acetylator status.
    Carr A
    Lancet; 1974 Aug; 2(7877):412. PubMed ID: 4136972
    [No Abstract]   [Full Text] [Related]  

  • 15. A double blind trial of phenelzine and amitriptyline in depressed out-patients.
    Kay DW; Garside RF; Fahy TJ
    Br J Psychiatry; 1974 Feb; 124(579):219. PubMed ID: 4596674
    [No Abstract]   [Full Text] [Related]  

  • 16. Metabolism and pharmacokinetics of phenelzine: lack of evidence for acetylation pathway in humans.
    Robinson DS; Cooper TB; Jindal SP; Corcella J; Lutz T
    J Clin Psychopharmacol; 1985 Dec; 5(6):333-7. PubMed ID: 4066998
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acetylation of phenelzine.
    Tilstone WJ; Margot P; Johnstone EC
    Psychopharmacology (Berl); 1979 Feb; 60(3):261-3. PubMed ID: 108703
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical consequences of polymorphic acetylation of basic drugs.
    Drayer DE; Reidenberg MM
    Clin Pharmacol Ther; 1977 Sep; 22(3):251-8. PubMed ID: 19187
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The myth of phenelzine acetylation.
    Marshall EF
    Br Med J; 1976 Oct; 2(6039):817. PubMed ID: 974644
    [No Abstract]   [Full Text] [Related]  

  • 20. Effects of phenelzine and acetylator phenotype.
    Rowan PR; Paykel ES; West PS; Rao BM; Taylor CN
    Neuropharmacology; 1981 Dec; 20(12B):1353-4. PubMed ID: 7322308
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.